NCT03964883View on ClinicalTrials.gov

Infliximab Blood Test in Crohn's Disease

CompletedOBSERVATIONAL

Enrollment

72

Participants

Timeline

Start Date

January 1, 2018

Primary Completion Date

March 1, 2018

Study Completion Date

March 31, 2018

Conditions

Crohn Disease

Trial Locations (1)

Unknown

Groupe Hospitalier Paris Saint Joseph, Paris

All Listed Sponsors

lead

Fondation Hôpital Saint-Joseph

OTHER

NCT03964883 - Infliximab Blood Test in Crohn's Disease | Biotech Hunter | Biotech Hunter